位置:首页 > 蛋白库 > BECN1_MOUSE
BECN1_MOUSE
ID   BECN1_MOUSE             Reviewed;         448 AA.
AC   O88597; Q99J03;
DT   21-FEB-2001, integrated into UniProtKB/Swiss-Prot.
DT   27-JUL-2011, sequence version 3.
DT   03-AUG-2022, entry version 183.
DE   RecName: Full=Beclin-1;
DE   AltName: Full=Coiled-coil myosin-like BCL2-interacting protein;
DE   Contains:
DE     RecName: Full=Beclin-1-C 35 kDa {ECO:0000303|PubMed:21364619};
DE   Contains:
DE     RecName: Full=Beclin-1-C 37 kDa {ECO:0000303|PubMed:21364619};
GN   Name=Becn1;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND FUNCTION.
RC   TISSUE=Brain;
RX   PubMed=10604474; DOI=10.1038/45257;
RA   Liang X.H., Jackson S., Seaman M., Brown K., Kempkes B., Hibshoosh H.,
RA   Levine B.;
RT   "Induction of autophagy and inhibition of tumorigenesis by beclin 1.";
RL   Nature 402:672-676(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=9765397; DOI=10.1128/jvi.72.11.8586-8596.1998;
RA   Liang X.H., Kleeman L.K., Jiang H.H., Gordon G., Goldman J.E., Berry G.,
RA   Herman B., Levine B.;
RT   "Protection against fatal Sindbis virus encephalitis by beclin, a novel
RT   Bcl-2-interacting protein.";
RL   J. Virol. 72:8586-8596(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Liver, Olfactory bulb, and Spinal ganglion;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X.,
RA   Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y.,
RA   Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S.,
RA   Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R.,
RA   Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K.,
RA   Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of the
RT   mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=129; TISSUE=Mammary tumor;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   SUBCELLULAR LOCATION, INTERACTION WITH GOPC AND GRID2, AND FUNCTION.
RX   PubMed=12372286; DOI=10.1016/s0896-6273(02)00861-9;
RA   Yue Z., Horton A., Bravin M., DeJager P.L., Selimi F., Heintz N.;
RT   "A novel protein complex linking the delta 2 glutamate receptor and
RT   autophagy: implications for neurodegeneration in lurcher mice.";
RL   Neuron 35:921-933(2002).
RN   [7]
RP   DISRUPTION PHENOTYPE.
RX   PubMed=14657337; DOI=10.1073/pnas.2436255100;
RA   Yue Z., Jin S., Yang C., Levine A.J., Heintz N.;
RT   "Beclin 1, an autophagy gene essential for early embryonic development, is
RT   a haploinsufficient tumor suppressor.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:15077-15082(2003).
RN   [8]
RP   INTERACTION WITH AMBRA1 AND PIK3C3.
RX   PubMed=17589504; DOI=10.1038/nature05925;
RA   Maria Fimia G., Stoykova A., Romagnoli A., Giunta L., Di Bartolomeo S.,
RA   Nardacci R., Corazzari M., Fuoco C., Ucar A., Schwartz P., Gruss P.,
RA   Piacentini M., Chowdhury K., Cecconi F.;
RT   "Ambra1 regulates autophagy and development of the nervous system.";
RL   Nature 447:1121-1125(2007).
RN   [9]
RP   FUNCTION, AND INTERACTION WITH ATG14; RUBCN; PIK3C3; PIK3R4 AND UVRAG.
RX   PubMed=19270693; DOI=10.1038/ncb1854;
RA   Zhong Y., Wang Q.J., Li X., Yan Y., Backer J.M., Chait B.T., Heintz N.,
RA   Yue Z.;
RT   "Distinct regulation of autophagic activity by Atg14L and Rubicon
RT   associated with Beclin 1-phosphatidylinositol-3-kinase complex.";
RL   Nat. Cell Biol. 11:468-476(2009).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, Lung, Spleen, and Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [11]
RP   PROTEOLYTIC CLEAVAGE, AND SUBCELLULAR LOCATION.
RX   PubMed=21364619; DOI=10.1038/cddis.2009.16;
RA   Wirawan E., Vande Walle L., Kersse K., Cornelis S., Claerhout S.,
RA   Vanoverberghe I., Roelandt R., De Rycke R., Verspurten J., Declercq W.,
RA   Agostinis P., Vanden Berghe T., Lippens S., Vandenabeele P.;
RT   "Caspase-mediated cleavage of Beclin-1 inactivates Beclin-1-induced
RT   autophagy and enhances apoptosis by promoting the release of proapoptotic
RT   factors from mitochondria.";
RL   Cell Death Dis. 1:E18-E18(2010).
RN   [12]
RP   INTERACTION WITH HMGB1.
RX   PubMed=20819940; DOI=10.1083/jcb.200911078;
RA   Tang D., Kang R., Livesey K.M., Cheh C.W., Farkas A., Loughran P.,
RA   Hoppe G., Bianchi M.E., Tracey K.J., Zeh H.J. III, Lotze M.T.;
RT   "Endogenous HMGB1 regulates autophagy.";
RL   J. Cell Biol. 190:881-892(2010).
RN   [13]
RP   INTERACTION WITH PIK3CB.
RX   PubMed=21059846; DOI=10.1083/jcb.201006056;
RA   Dou Z., Chattopadhyay M., Pan J.-A., Guerriero J.L., Jiang Y.-P.,
RA   Ballou L.M., Yue Z., Lin R.Z., Zong W.-X.;
RT   "The class IA phosphatidylinositol 3-kinase p110-beta subunit is a positive
RT   regulator of autophagy.";
RL   J. Cell Biol. 191:827-843(2010).
RN   [14]
RP   INTERACTION WITH SLAMF1.
RX   PubMed=22493499; DOI=10.1074/jbc.m112.367060;
RA   Ma C., Wang N., Detre C., Wang G., O'Keeffe M., Terhorst C.;
RT   "Receptor signaling lymphocyte-activation molecule family 1 (Slamf1)
RT   regulates membrane fusion and NADPH oxidase 2 (NOX2) activity by recruiting
RT   a Beclin-1/Vps34/ultraviolet radiation resistance-associated gene (UVRAG)
RT   complex.";
RL   J. Biol. Chem. 287:18359-18365(2012).
RN   [15]
RP   PHOSPHORYLATION AT SER-91 AND SER-94, MUTAGENESIS OF SER-91 AND SER-94, AND
RP   IDENTIFICATION IN A COMPLEX WITH PIK3C3; PIK3R4; UVRAG AND ATG14.
RX   PubMed=23332761; DOI=10.1016/j.cell.2012.12.016;
RA   Kim J., Kim Y.C., Fang C., Russell R.C., Kim J.H., Fan W., Liu R.,
RA   Zhong Q., Guan K.L.;
RT   "Differential regulation of distinct Vps34 complexes by AMPK in nutrient
RT   stress and autophagy.";
RL   Cell 152:290-303(2013).
RN   [16]
RP   FUNCTION, DISRUPTION PHENOTYPE, AND SUBCELLULAR LOCATION.
RX   PubMed=25275521; DOI=10.1371/journal.pgen.1004626;
RA   McKnight N.C., Zhong Y., Wold M.S., Gong S., Phillips G.R., Dou Z.,
RA   Zhao Y., Heintz N., Zong W.X., Yue Z.;
RT   "Beclin 1 is required for neuron viability and regulates endosome pathways
RT   via the UVRAG-VPS34 complex.";
RL   PLoS Genet. 10:E1004626-E1004626(2014).
RN   [17]
RP   FUNCTION.
RX   PubMed=28445460; DOI=10.1038/nature22078;
RA   Ashkenazi A., Bento C.F., Ricketts T., Vicinanza M., Siddiqi F., Pavel M.,
RA   Squitieri F., Hardenberg M.C., Imarisio S., Menzies F.M., Rubinsztein D.C.;
RT   "Polyglutamine tracts regulate beclin 1-dependent autophagy.";
RL   Nature 545:108-111(2017).
RN   [18]
RP   INTERACTION WITH TRIM50.
RX   PubMed=29604308; DOI=10.1016/j.bbamcr.2018.03.011;
RA   Fusco C., Mandriani B., Di Rienzo M., Micale L., Malerba N.,
RA   Cocciadiferro D., Sjoettem E., Augello B., Squeo G.M., Pellico M.T.,
RA   Jain A., Johansen T., Fimia G.M., Merla G.;
RT   "TRIM50 regulates Beclin 1 proautophagic activity.";
RL   Biochim. Biophys. Acta 1865:908-919(2018).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 106-124 IN COMPLEX WITH MUHV-4 M11
RP   (MICROBIAL INFECTION).
RX   PubMed=18248095; DOI=10.1371/journal.ppat.0040025;
RA   Ku B., Woo J.S., Liang C., Lee K.H., Hong H.S., E X., Kim K.S., Jung J.U.,
RA   Oh B.H.;
RT   "Structural and biochemical bases for the inhibition of autophagy and
RT   apoptosis by viral BCL-2 of murine gamma-herpesvirus 68.";
RL   PLoS Pathog. 4:E25-E25(2008).
CC   -!- FUNCTION: Plays a central role in autophagy (PubMed:10604474,
CC       PubMed:12372286, PubMed:19270693, PubMed:28445460). Acts as core
CC       subunit of different PI3K complex forms that mediate formation of
CC       phosphatidylinositol 3-phosphate and are believed to play a role in
CC       multiple membrane trafficking pathways: PI3KC3-C1 is involved in
CC       initiation of autophagosomes and PI3KC3-C2 in maturation of
CC       autophagosomes and endocytosis (PubMed:19270693, PubMed:25275521).
CC       Involved in regulation of degradative endocytic trafficking and
CC       required for the abcission step in cytokinesis, probably in the context
CC       of PI3KC3-C2 (By similarity). Essential for the formation of PI3KC3-C2
CC       but not PI3KC3-C1 PI3K complex forms (PubMed:25275521). Involved in
CC       endocytosis including endosome formation in neuronal cells
CC       (PubMed:25275521). May play a role in antiviral host defense (By
CC       similarity). {ECO:0000250|UniProtKB:Q14457,
CC       ECO:0000269|PubMed:10604474, ECO:0000269|PubMed:12372286,
CC       ECO:0000269|PubMed:19270693, ECO:0000269|PubMed:25275521,
CC       ECO:0000269|PubMed:28445460}.
CC   -!- FUNCTION: Beclin-1-C 35 kDa localized to mitochondria can promote
CC       apoptosis; it induces the mitochondrial translocation of BAX and the
CC       release of proapoptotic factors (By similarity).
CC       {ECO:0000250|UniProtKB:Q14457}.
CC   -!- SUBUNIT: A homodimeric form is proposed to exist; this metastable form
CC       readily transits to ATG14- or UVRAG-containing complexes with
CC       BECN1:UVRAG being more stable than BECN1:ATG14 (By similarity).
CC       Component of the PI3K (PI3KC3/PI3K-III/class III phosphatidylinositol
CC       3-kinase) complex whose core is composed of the catalytic subunit
CC       PIK3C3, the regulatory subunit PIK3R4 and BECN1, and associates with
CC       additional regulatory/auxilliary subunits to form alternative complex
CC       forms. Accepted alternative complex forms containing a forth regulatory
CC       subunit in a mutually exclusive manner are PI3K complex I (PI3KC3-C1)
CC       containing ATG14, and PI3K complex II (PI3KC3-C2) containing UVRAG
CC       (PubMed:19270693, PubMed:23332761). PI3KC3-C1 displays a V-shaped
CC       architecture with PIK3R4 serving as a bridge between PIK3C3 and the
CC       ATG14:BECN1 subcomplex (By similarity). Both, PI3KC3-C1 and PI3KC3-C2,
CC       can associate with further regulatory subunits, such as RUBCN,
CC       SH3GLB1/Bif-1 and AMBRA1 (PubMed:19270693). PI3KC3-C1 probably
CC       associates with PIK3CB (PubMed:21059846.) Interacts with AMBRA1, GOPC,
CC       GRID2 and PIK3CB (PubMed:12372286, PubMed:17589504). Forms a complex
CC       with PPP2CA and AMBRA1; AMBRA1 and BECN1 components of the complex
CC       regulate MYC stability via different pathways (By similarity).
CC       Interacts with BCL2 and BCL2L1 isoform Bcl-X(L); the interaction
CC       inhibits BECN1 function in promoting autophagy by interfering with the
CC       formation of the PI3K complex (By similarity). Interacts with cytosolic
CC       HMGB1; inhibits the interaction of BECN1 and BCL2 leading to promotion
CC       of autophagy (PubMed:20819940). Interacts with USP10, USP13, VMP1,
CC       DAPK1 (By similarity). Interacts with the poly-Gln domain of ATXN3; the
CC       interaction causes deubiquitination at Lys-400 and stabilizes BECN1
CC       (PubMed:28445460). Interacts with SLAMF1 (PubMed:22493499). Interacts
CC       with TRIM5; the interaction causes activation of BECN1 by causing its
CC       dissociation from its inhibitors BCL2 and TAB2 (By similarity).
CC       Interacts with active ULK1 (phosphorylated on 'Ser-317') and MEFV
CC       simultaneously (By similarity). Interacts with TRIM50
CC       (PubMed:29604308). Interacts with TRIM16 (By similarity). Interacts
CC       with WDR81 and WDR91; negatively regulates the PI3 kinase/PI3K activity
CC       associated with endosomal membranes (By similarity). Interacts with
CC       LAPTM4B; competes with EGFR for LAPTM4B binding; regulates EGFR
CC       activity (By similarity). Interacts with ATG14; this interaction is
CC       increased in the absence of TMEM39A (By similarity). Interacts with
CC       WASHC1; preventing interaction with AMBRA1 and the DCX(AMBRA1) complex
CC       and subsequent ubiquitination (By similarity). Interacts with TRIM17
CC       (By similarity). Interacts with BCL2L10/BCL-B (via BH1 domain) (By
CC       similarity). {ECO:0000250|UniProtKB:Q14457,
CC       ECO:0000250|UniProtKB:Q91XJ1, ECO:0000269|PubMed:12372286,
CC       ECO:0000269|PubMed:17589504, ECO:0000269|PubMed:18248095,
CC       ECO:0000269|PubMed:19270693, ECO:0000269|PubMed:20819940,
CC       ECO:0000269|PubMed:21059846, ECO:0000269|PubMed:22493499,
CC       ECO:0000269|PubMed:23332761, ECO:0000269|PubMed:29604308, ECO:0000305,
CC       ECO:0000305|PubMed:28445460}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with murine gammaherpesvirus
CC       68 M11; the viral protein binds BECN1 with higher affinity than
CC       cellular BCL2. {ECO:0000269|PubMed:18248095}.
CC   -!- INTERACTION:
CC       O88597; P10417: Bcl2; NbExp=11; IntAct=EBI-643716, EBI-526314;
CC       O88597; Q8BH60: Gopc; NbExp=5; IntAct=EBI-643716, EBI-296357;
CC       O88597; P63158: Hmgb1; NbExp=3; IntAct=EBI-643716, EBI-6665811;
CC       O88597; Q8VCQ3: Nrbf2; NbExp=5; IntAct=EBI-643716, EBI-2365563;
CC       O88597; Q6PF93: Pik3c3; NbExp=6; IntAct=EBI-643716, EBI-6678149;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:12372286}. Golgi
CC       apparatus, trans-Golgi network membrane {ECO:0000250|UniProtKB:Q14457};
CC       Peripheral membrane protein {ECO:0000250|UniProtKB:Q14457}. Endosome
CC       membrane {ECO:0000250|UniProtKB:Q14457}; Peripheral membrane protein
CC       {ECO:0000250|UniProtKB:Q14457}. Endoplasmic reticulum membrane
CC       {ECO:0000250|UniProtKB:Q14457}; Peripheral membrane protein
CC       {ECO:0000250|UniProtKB:Q14457}. Mitochondrion membrane
CC       {ECO:0000250|UniProtKB:Q14457}; Peripheral membrane protein
CC       {ECO:0000250|UniProtKB:Q14457}. Endosome {ECO:0000269|PubMed:25275521}.
CC       Cytoplasmic vesicle, autophagosome {ECO:0000305}. Note=Interaction with
CC       ATG14 promotes translocation to autophagosomes (By similarity).
CC       Expressed in dendrites and cell bodies of cerebellar Purkinje cells.
CC       Localized to endosomes in neurons (PubMed:25275521).
CC       {ECO:0000250|UniProtKB:Q14457, ECO:0000269|PubMed:12372286,
CC       ECO:0000269|PubMed:25275521}.
CC   -!- SUBCELLULAR LOCATION: [Beclin-1-C 35 kDa]: Mitochondrion
CC       {ECO:0000269|PubMed:21364619}. Nucleus {ECO:0000250|UniProtKB:Q14457}.
CC       Cytoplasm {ECO:0000250|UniProtKB:Q14457}.
CC   -!- SUBCELLULAR LOCATION: [Beclin-1-C 37 kDa]: Mitochondrion
CC       {ECO:0000269|PubMed:21364619}.
CC   -!- DOMAIN: The coiled coil domain can form antiparallel homodimers and
CC       mediates dimerization with the coiled coil domains of ATG14 or UVRAG
CC       involved in the formation of PI3K complexes.
CC       {ECO:0000250|UniProtKB:Q91XJ1}.
CC   -!- DOMAIN: The C-terminal evolutionary conserved domain (ECD) contains
CC       poly-Gln-binding domains such as the ATXN3 poly-Gln motif, consistent
CC       with structural docking models revealing two highly scored poly-Gln-
CC       binding pockets in the ECD. As some binding is observed with BECN1
CC       lacking the ECD, other domains of BECN1 may also interact with ATXN3.
CC       {ECO:0000305|PubMed:28445460}.
CC   -!- PTM: Phosphorylation at Thr-117 by DAPK1 reduces its interaction with
CC       BCL2 and BCL2L1 and promotes induction of autophagy (By similarity). In
CC       response to autophagic stimuli, phosphorylated at serine residues by
CC       AMPK in an ATG14-dependent manner, and this phosphorylation is critical
CC       for maximally efficient autophagy. {ECO:0000250|UniProtKB:Q14457,
CC       ECO:0000269|PubMed:23332761}.
CC   -!- PTM: Polyubiquitinated by NEDD4, both with 'Lys-11'- and 'Lys-63'-
CC       linkages (By similarity). 'Lys-11'-linked poyubiquitination leads to
CC       degradation and is enhanced when the stabilizing interaction partner
CC       VPS34 is depleted (By similarity). Deubiquitinated by USP10 and USP13,
CC       leading to stabilize the PIK3C3/VPS34-containing complexes (By
CC       similarity). Polyubiquitinated at Lys-400 with 'Lys-48'-linkages
CC       (PubMed:28445460). 'Lys-48'-linked poyubiquitination of Lys-400 leads
CC       to degradation (PubMed:28445460). Deubiquitinated by ATXN3, leading to
CC       stabilization (PubMed:28445460). Ubiquitinated at Lys-435 via 'Lys-63'-
CC       linkage by the DCX(AMBRA1) complex, thereby increasing the association
CC       between BECN1 and PIK3C3 to promote PIK3C3 activity (By similarity).
CC       {ECO:0000250|UniProtKB:Q14457, ECO:0000269|PubMed:28445460}.
CC   -!- PTM: Proteolytically processed by caspases including CASP8 and CASP3;
CC       the C-terminal fragments lack autophagy-inducing capacity and are
CC       proposed to induce apoptosis. Thus the cleavage is proposed to be an
CC       determinant to switch from autophagy to apoptosis pathways affecting
CC       cellular homeostasis including viral infections and survival of tumor
CC       cells. {ECO:0000305|PubMed:21364619}.
CC   -!- DISRUPTION PHENOTYPE: Death early in embryogenesis. Embryos show a
CC       severely altered autophagic response, whereas their apoptotic response
CC       to serum withdrawal or UV light is normal (PubMed:14657337).
CC       Accelerated neurodegeneration (conditional knockout in cerebellar
CC       Purkinje cells). {ECO:0000269|PubMed:14657337,
CC       ECO:0000269|PubMed:25275521}.
CC   -!- MISCELLANEOUS: Expanded poly-Gln tracts inhibit ATXN3-BECN1
CC       interaction, decrease BECN1 levels and impair starvation-induced
CC       autophagy (PubMed:28445460). {ECO:0000269|PubMed:28445460}.
CC   -!- SIMILARITY: Belongs to the beclin family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF077302; AAC68654.2; -; mRNA.
DR   EMBL; AK032176; BAC27745.1; -; mRNA.
DR   EMBL; AK050329; BAC34192.1; -; mRNA.
DR   EMBL; AK083800; BAC39021.1; -; mRNA.
DR   EMBL; AL590969; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC005770; AAH05770.1; -; mRNA.
DR   CCDS; CCDS25462.1; -.
DR   RefSeq; NP_062530.2; NM_019584.3.
DR   PDB; 3BL2; X-ray; 2.30 A; C/D=106-124.
DR   PDB; 5YR0; X-ray; 1.90 A; A=174-223.
DR   PDBsum; 3BL2; -.
DR   PDBsum; 5YR0; -.
DR   AlphaFoldDB; O88597; -.
DR   SMR; O88597; -.
DR   BioGRID; 207843; 12.
DR   ComplexPortal; CPX-75; Phosphatidylinositol 3-kinase complex, class III, ATG14 variant.
DR   ComplexPortal; CPX-76; Phosphatidylinositol 3-kinase complex, class III, UVRAG variant.
DR   CORUM; O88597; -.
DR   DIP; DIP-41636N; -.
DR   IntAct; O88597; 17.
DR   MINT; O88597; -.
DR   STRING; 10090.ENSMUSP00000119369; -.
DR   iPTMnet; O88597; -.
DR   PhosphoSitePlus; O88597; -.
DR   EPD; O88597; -.
DR   MaxQB; O88597; -.
DR   PaxDb; O88597; -.
DR   PRIDE; O88597; -.
DR   ProteomicsDB; 273601; -.
DR   Antibodypedia; 4116; 1645 antibodies from 47 providers.
DR   DNASU; 56208; -.
DR   Ensembl; ENSMUST00000130916; ENSMUSP00000119369; ENSMUSG00000035086.
DR   GeneID; 56208; -.
DR   KEGG; mmu:56208; -.
DR   UCSC; uc007loj.1; mouse.
DR   CTD; 8678; -.
DR   MGI; MGI:1891828; Becn1.
DR   VEuPathDB; HostDB:ENSMUSG00000035086; -.
DR   eggNOG; KOG2751; Eukaryota.
DR   GeneTree; ENSGT00390000008164; -.
DR   HOGENOM; CLU_024219_4_1_1; -.
DR   InParanoid; O88597; -.
DR   OMA; DTFCIGH; -.
DR   OrthoDB; 1085752at2759; -.
DR   PhylomeDB; O88597; -.
DR   TreeFam; TF314282; -.
DR   Reactome; R-MMU-1632852; Macroautophagy.
DR   Reactome; R-MMU-5689880; Ub-specific processing proteases.
DR   BioGRID-ORCS; 56208; 18 hits in 76 CRISPR screens.
DR   ChiTaRS; Becn1; mouse.
DR   EvolutionaryTrace; O88597; -.
DR   PRO; PR:O88597; -.
DR   Proteomes; UP000000589; Chromosome 11.
DR   RNAct; O88597; protein.
DR   Bgee; ENSMUSG00000035086; Expressed in renal medulla collecting duct and 253 other tissues.
DR   ExpressionAtlas; O88597; baseline and differential.
DR   Genevisible; O88597; MM.
DR   GO; GO:0005776; C:autophagosome; IDA:MGI.
DR   GO; GO:0005737; C:cytoplasm; IDA:MGI.
DR   GO; GO:0031410; C:cytoplasmic vesicle; IDA:MGI.
DR   GO; GO:0005856; C:cytoskeleton; ISS:MGI.
DR   GO; GO:0005829; C:cytosol; ISO:MGI.
DR   GO; GO:0030425; C:dendrite; ISO:MGI.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISO:MGI.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005768; C:endosome; ISO:MGI.
DR   GO; GO:0010008; C:endosome membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0019898; C:extrinsic component of membrane; ISO:MGI.
DR   GO; GO:0016020; C:membrane; ISS:MGI.
DR   GO; GO:0031966; C:mitochondrial membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005739; C:mitochondrion; ISO:MGI.
DR   GO; GO:0016604; C:nuclear body; ISO:MGI.
DR   GO; GO:0005634; C:nucleus; ISO:MGI.
DR   GO; GO:0045335; C:phagocytic vesicle; IDA:MGI.
DR   GO; GO:0000407; C:phagophore assembly site; IBA:GO_Central.
DR   GO; GO:0035032; C:phosphatidylinositol 3-kinase complex, class III; IDA:UniProtKB.
DR   GO; GO:0034271; C:phosphatidylinositol 3-kinase complex, class III, type I; IBA:GO_Central.
DR   GO; GO:0034272; C:phosphatidylinositol 3-kinase complex, class III, type II; IBA:GO_Central.
DR   GO; GO:0032991; C:protein-containing complex; IDA:MGI.
DR   GO; GO:0005802; C:trans-Golgi network; IDA:MGI.
DR   GO; GO:0051020; F:GTPase binding; ISO:MGI.
DR   GO; GO:0042802; F:identical protein binding; IPI:MGI.
DR   GO; GO:0043548; F:phosphatidylinositol 3-kinase binding; ISO:MGI.
DR   GO; GO:0019901; F:protein kinase binding; ISO:MGI.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; ISO:MGI.
DR   GO; GO:0007568; P:aging; IEA:Ensembl.
DR   GO; GO:0050435; P:amyloid-beta metabolic process; IMP:MGI.
DR   GO; GO:0001525; P:angiogenesis; TAS:UniProtKB.
DR   GO; GO:0006915; P:apoptotic process; IEA:UniProtKB-KW.
DR   GO; GO:0000045; P:autophagosome assembly; IMP:UniProtKB.
DR   GO; GO:0097352; P:autophagosome maturation; ISO:MGI.
DR   GO; GO:0006914; P:autophagy; IDA:CAFA.
DR   GO; GO:0000422; P:autophagy of mitochondrion; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0071275; P:cellular response to aluminum ion; IEA:Ensembl.
DR   GO; GO:0034198; P:cellular response to amino acid starvation; IEA:Ensembl.
DR   GO; GO:0071280; P:cellular response to copper ion; IEA:Ensembl.
DR   GO; GO:0071364; P:cellular response to epidermal growth factor stimulus; IEA:Ensembl.
DR   GO; GO:0042149; P:cellular response to glucose starvation; IDA:UniProtKB.
DR   GO; GO:0070301; P:cellular response to hydrogen peroxide; IEA:Ensembl.
DR   GO; GO:0006995; P:cellular response to nitrogen starvation; IBA:GO_Central.
DR   GO; GO:0051607; P:defense response to virus; IEA:UniProtKB-KW.
DR   GO; GO:0045022; P:early endosome to late endosome transport; ISS:UniProtKB.
DR   GO; GO:0043652; P:engulfment of apoptotic cell; IMP:CACAO.
DR   GO; GO:0045324; P:late endosome to vacuole transport; IBA:GO_Central.
DR   GO; GO:0007040; P:lysosome organization; IMP:MGI.
DR   GO; GO:0016236; P:macroautophagy; IMP:UniProtKB.
DR   GO; GO:0000423; P:mitophagy; ISO:MGI.
DR   GO; GO:0007080; P:mitotic metaphase plate congression; ISO:MGI.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IMP:ParkinsonsUK-UCL.
DR   GO; GO:1902902; P:negative regulation of autophagosome assembly; IMP:MGI.
DR   GO; GO:0010507; P:negative regulation of autophagy; IMP:MGI.
DR   GO; GO:0060548; P:negative regulation of cell death; ISO:MGI.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; IDA:MGI.
DR   GO; GO:1905672; P:negative regulation of lysosome organization; ISO:MGI.
DR   GO; GO:2000378; P:negative regulation of reactive oxygen species metabolic process; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0048666; P:neuron development; IMP:MGI.
DR   GO; GO:0036092; P:phosphatidylinositol-3-phosphate biosynthetic process; ISO:MGI.
DR   GO; GO:1902425; P:positive regulation of attachment of mitotic spindle microtubules to kinetochore; ISO:MGI.
DR   GO; GO:2000786; P:positive regulation of autophagosome assembly; ISO:MGI.
DR   GO; GO:0010508; P:positive regulation of autophagy; ISS:UniProtKB.
DR   GO; GO:0010613; P:positive regulation of cardiac muscle hypertrophy; IMP:MGI.
DR   GO; GO:2001244; P:positive regulation of intrinsic apoptotic signaling pathway; ISS:UniProtKB.
DR   GO; GO:0006468; P:protein phosphorylation; ISO:MGI.
DR   GO; GO:0006622; P:protein targeting to lysosome; IC:ComplexPortal.
DR   GO; GO:0032801; P:receptor catabolic process; ISO:MGI.
DR   GO; GO:0010506; P:regulation of autophagy; ISO:MGI.
DR   GO; GO:0050790; P:regulation of catalytic activity; IMP:MGI.
DR   GO; GO:0032465; P:regulation of cytokinesis; ISS:UniProtKB.
DR   GO; GO:0016241; P:regulation of macroautophagy; ISO:MGI.
DR   GO; GO:0001666; P:response to hypoxia; IEA:Ensembl.
DR   GO; GO:0010040; P:response to iron(II) ion; IEA:Ensembl.
DR   GO; GO:0010288; P:response to lead ion; IEA:Ensembl.
DR   GO; GO:0098780; P:response to mitochondrial depolarisation; ISO:MGI.
DR   GO; GO:0051707; P:response to other organism; IDA:MGI.
DR   GO; GO:0033197; P:response to vitamin E; IEA:Ensembl.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IEA:Ensembl.
DR   DisProt; DP01612; -.
DR   Gene3D; 1.10.418.40; -; 1.
DR   IDEAL; IID50268; -.
DR   InterPro; IPR007243; Atg6/Beclin.
DR   InterPro; IPR038274; Atg6/Beclin_C_sf.
DR   InterPro; IPR041691; Atg6/beclin_CC.
DR   InterPro; IPR040455; Atg6_BARA.
DR   InterPro; IPR032913; BECN1.
DR   InterPro; IPR029318; BH3_dom.
DR   PANTHER; PTHR12768; PTHR12768; 1.
DR   PANTHER; PTHR12768:SF6; PTHR12768:SF6; 1.
DR   Pfam; PF04111; APG6; 1.
DR   Pfam; PF17675; APG6_N; 1.
DR   Pfam; PF15285; BH3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Antiviral defense; Apoptosis; Autophagy;
KW   Cell cycle; Cell division; Coiled coil; Cytoplasm; Cytoplasmic vesicle;
KW   Endocytosis; Endoplasmic reticulum; Endosome; Golgi apparatus;
KW   Isopeptide bond; Membrane; Mitochondrion; Nucleus; Phosphoprotein;
KW   Reference proteome; Ubl conjugation.
FT   CHAIN           1..448
FT                   /note="Beclin-1"
FT                   /id="PRO_0000218556"
FT   CHAIN           132..448
FT                   /note="Beclin-1-C 37 kDa"
FT                   /evidence="ECO:0000305|PubMed:21364619"
FT                   /id="PRO_0000435038"
FT   CHAIN           148..448
FT                   /note="Beclin-1-C 35 kDa"
FT                   /evidence="ECO:0000305|PubMed:21364619"
FT                   /id="PRO_0000435039"
FT   REGION          47..66
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          110..157
FT                   /note="Interaction with BCL2 and BCL2L1 isoform Bcl-X(L)"
FT                   /evidence="ECO:0000250|UniProtKB:Q14457"
FT   REGION          243..448
FT                   /note="Evolutionary conserved domain (ECD)"
FT                   /evidence="ECO:0000305|PubMed:28445460"
FT   REGION          423..448
FT                   /note="Required for membrane-association"
FT                   /evidence="ECO:0000250|UniProtKB:Q14457"
FT   COILED          140..268
FT                   /evidence="ECO:0000255"
FT   MOTIF           106..125
FT                   /note="BH3"
FT                   /evidence="ECO:0000250|UniProtKB:Q14457"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14457"
FT   MOD_RES         14
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14457"
FT   MOD_RES         29
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q14457"
FT   MOD_RES         88
FT                   /note="Phosphoserine; by AMPK"
FT                   /evidence="ECO:0000250|UniProtKB:Q14457"
FT   MOD_RES         91
FT                   /note="Phosphoserine; by AMPK"
FT                   /evidence="ECO:0000269|PubMed:23332761"
FT   MOD_RES         94
FT                   /note="Phosphoserine; by AMPK"
FT                   /evidence="ECO:0000269|PubMed:23332761"
FT   MOD_RES         117
FT                   /note="Phosphothreonine; by DAPK1"
FT                   /evidence="ECO:0000250|UniProtKB:Q14457"
FT   CROSSLNK        400
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:Q14457"
FT   CROSSLNK        435
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin)"
FT                   /evidence="ECO:0000250|UniProtKB:Q14457"
FT   MUTAGEN         91
FT                   /note="S->A: Complete loss of phosphorylation. Complete
FT                   loss of phosphorylation and defective autophagic function;
FT                   when associated with Ala-94."
FT                   /evidence="ECO:0000269|PubMed:23332761"
FT   MUTAGEN         94
FT                   /note="S->A: Partial loss of phosphorylation. Complete loss
FT                   of phosphorylation and defective autophagic function; when
FT                   associated with Ala-91."
FT                   /evidence="ECO:0000269|PubMed:23332761"
FT   CONFLICT        37
FT                   /note="T -> A (in Ref. 2; AAC68654)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        228
FT                   /note="Q -> H (in Ref. 2; AAC68654)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        268
FT                   /note="F -> L (in Ref. 2; AAC68654)"
FT                   /evidence="ECO:0000305"
FT   HELIX           107..121
FT                   /evidence="ECO:0007829|PDB:3BL2"
FT   HELIX           176..221
FT                   /evidence="ECO:0007829|PDB:5YR0"
SQ   SEQUENCE   448 AA;  51589 MW;  14623BA002E1AAEE CRC64;
     MEGSKASSST MQVSFVCQRC SQPLKLDTSF KILDRVTIQE LTAPLLTTAQ AKPGETQEEE
     ANSGEEPFIE TRQDGVSRRF IPPARMMSTE SANSFTLIGE ASDGGTMENL SRRLKVTGDL
     FDIMSGQTDV DHPLCEECTD TLLDQLDTQL NVTENECQNY KRCLEILEQM NEDDSEQLQR
     ELKELALEEE RLIQELEDVE KNRKVVAENL EKVQAEAERL DQEEAQYQRE YSEFKRQQLE
     LDDELKSVEN QVRYAQIQLD KLKKTNVFNA TFHIWHSGQF GTINNFRLGR LPSVPVEWNE
     INAAWGQTVL LLHALANKMG LKFQRYRLVP YGNHSYLESL TDKSKELPLY CSGGLRFFWD
     NKFDHAMVAF LDCVQQFKEE VEKGETRFCL PYRMDVEKGK IEDTGGSGGS YSIKTQFNSE
     EQWTKALKFM LTNLKWGLAW VSSQFYNK
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024